Brain Cancer Awareness
May is Brain Cancer Awareness Month and is an opportunity to rally support and awareness for the more than 1.3 million people living with a primary brain tumor in the United States1.
Facts and Stats
- Not all brain tumors are cancerous. In fact, 74% of brain tumors are benign or non-cancerous.
- Around 108,800 people will be diagnosed with a brain tumor this year.
- Glioblastoma is the most commonly occurring primary malignant brain tumor, accounting for 13.7% of all tumors and 52.2% of all malignant tumors.
- The median age at diagnosis for a primary brain tumor is 62 years.
Onco360 understands that brain cancer can significantly impact the daily life of patients and we are here to help. We offer expert and compassionate oncology care with many treatment options, expert clinical support, and financial assistance sourcing for eligible patients.
It is common for individuals battling brain tumors and brain cancer to experience cognitive issues such as difficulty concentrating, mental slowing, memory loss, problems understanding, or problems organizing thoughts. Since taking medications on time and as prescribed is critical, we offer free blister packaging. Talk to a member of our pharmacy team at 877.662.6633 to see if your medication is eligible for blister packing to eliminate any confusion around timing and dosage.
Onco360 Dispenses the Latest Oncology Products to Treat Brain Cancer **
**This list is a small portion of the comprehensive medications Onco360 can provide. Contact your account team for a full listing.
Avastin® (bevacizumab)
Carboplatin
Carmustine
Cisplatin
Cotellic® (cobimetinib)
Cyclophosphamide
Cytarabine
Erivedge® (vismodegib)
Etoposide
Everolimus
Gleostine® (lomustine)
Gomekli™ (mirdametinib)
Irinotecan
Koselugo® (selumetinib)
Lomustine
Mekinist® (trametinib)
Methotrexate
Modeyso™ (dordaviprone)
Ojemda® (tovorafenib)
Pemetrexed
Rituxan® (rituximab)
Rozlytrek® (entrectinib)
Sunitinib
Tabloid® (thioguanine)
Tafinlar® (dabrafenib)
Temodar® (temozolomide)
Topotecan
Vincristine
Voranigo® (vorasidenib)
Welireg® (belzutifan)
Zelboraf® (vemurafenib)
Why Onco360?
-
Timing is crucial when it comes to your complex treatment plan, and as the specialty medication experts, we will work as your advocate with your physician, insurance company, and others involved in your treatment.
-
We will make sure you understand your medications, their dosage, and any potential side effects. Our clinicians and pharmacists are on call 24/7 if you have any issues at 877.662.6633.
-
We will ship your medications to you as quickly as possible with complimentary overnight shipping to your doorstep.
Best-in-class OncoAdvocate® Team
explores funding options for qualified
patients quickly with our proprietary
Funding FastTrack program and sourced
$149 million in total funding
for our patients in 2025
97% of our brain cancer patients
paid less than $50
for their last dispense
Currently, our brain cancer patients’
average copay is $23
Go Gray in May
Go Gray in May on May 27th to raise awareness and show support for brain tumor patients and their families.
Wear gray and show your support on social media using the hashtag #GoGrayinMay.
Helpful Resources
If you would like to read further about brain tumors or brain cancer, here are some recommended resources:
1https://braintumor.org/brain-tumors/about-brain-tumors/brain-tumor-facts/